Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p.

BACKGROUND: Early and accurate diagnosis of ischaemic stroke (IS) requires the use of an optimized biomarker. Exosomal microRNAs have the potential to serve as biomarkers owing to their stability and specificity. We investigated the expression levels of plasma-derived exosomal microRNA-21-5p and microRNA-30a-5p in the different phases of IS. METHODS: One hundred forty-three patients with IS and 24 non-stroke controls were enrolled. The patients were divided into the following 5 groups: 1 group for the hyperacute phase IS (HIS, within 6 h); two for the acute phase IS (AIS, including days 1-3 and days 4-7); one for the subacute phase IS (SIS, days 8-14); and one for the recovery phase IS (RIS, days >14). Plasma exosomes were isolated using a QIAGEN exoRNeasy kit and examined by transmission electron -microscopy, nanoparticle tracking, and flow cytometry. The expression levels of miRNA-21-5p and miRNA-30a-5p were detected by quantitative real-time polymerase chain reaction. RESULTS: The plasma exosomal miR-21-5p levels in SIS and RIS were significantly higher than that in controls (p < 0.05 and p < 0.01 respectively). The levels of miR-30a-5p in HIS were significantly higher (p < 0.05) and in AIS (days 1-3) were lower than that in controls (p < 0.05). In AIS (days 1-3), both miRNAs were decreased compared with the HIS group (p = 0.053 and 0.001, respectively). The area under the curve (AUC) of the miR-21-5p was 0.714 for SIS (95% CI 0.570-0.859, p = 0.007), 0.734 for RIS (95% CI 0.596-0.871, p = 0.003); the AUC of the miR-30a-5p was 0.826 for HIS (95% CI 0.665-0.988, p = 0.001), 0.438 for AIS (days 1-3; 95% CI 0.240-0.635, p = 0.516). CONCLUSIONS: The plasma-derived exosomal miR-21-5p and miRNA-30a-5p in combination are promising biomarkers for diagnosing IS and distinguishing among HIS, SIS, and RIS, especially miRNA-30a-5p for the diagnosis of the HIS phase. Our results provide a new reference for clinicians to apply in early-stage diagnosis and identifies the possible value of biomarkers for IS thrombolysis therapy.

[Mechanisms and Influencing Factors of Antibiotic Removal in Sewage Biological Treatment].

Antibiotic pollution in the environment is becoming increasingly serious, and the induced antibiotic resistance has become a major threat to human health. A literature review of the antibiotic concentration in the influent and effluent of many sewage treatment plants around the world has shown that current sewage treatment processes do not effectively remove antibiotics. Studies have shown that adsorption and biodegradation are the main ways of removing antibiotics from sewage. The mechanisms of adsorption and the different adsorption extents of diverse antibiotics were analyzed in this paper. Biodegradation of antibiotics in a biological sewage treatment process were analyzed in terms of biodegradability, degrading bacteria, and degradation products. The effects of the operation conditions of biological sewage treatment processes, such as hydraulic retention time, sludge retention time, temperature, and process selection (conventional activated sludge, membrane bioreactor, or biological nitrogen removal processes), on adsorption and biodegradation pathways as well as on the removal efficiency of antibiotics are also discussed. The effects of bacterial composition, growth substrate, and coexisting micro-pollutants on the fate of antibiotics in biological wastewater treatment require more in-depth research.

Plasma Exosomal miR-422a and miR-125b-2-3p Serve as Biomarkers for Ischemic Stroke.

BACKGROUND: MircroRNA (MiRNA) levels are associated with disease pathophysiology and are high in plasma exosomes. Plasma exosomal miRNAs serve as potential therapeutic targets and diagnosis biomarkers in some diseases but few studies have examined them in Ischemic Stroke (IS). Therefore, we explored the potential predictive value of plasma exosomal miR-422a and miR-125b-2-3p in different IS phases (acute and subacute phases). METHODS: Fifty-five IS patients and 25 age and sex matched healthy controls were recruited. Patients were classified into two groups: 27 patients in acute phase (days 1-3) and 28 patients in subacute phase (days 4-14). The plasma exosomal levels of miR-422a and miR-125b-2-3p were examined via quantitative real-time polymerase chain reaction (qRT-PCR). The Areas Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve were constructed to evaluate the diagnostic accuracy of these miRNAs in IS. RESULTS: The expression levels of plasma exosomal miR-422a and miR-125b-2-3p were significantly decreased in the subacute phase group (P<0.001, P<0.001, respectively), and the miR-422a levels were increased in the acute phase group (P<0.005) as compared to the controls. Additionally, the expression levels of plasma exosomal miR-422a and miR-125b-2-3p were significantly decreased in the subacute phase group than in the acute phase group (P<0.001, P<0.005, respectively). ROC analysis showed high AUC values for miR-422a and miR-125b-2-3p in the subacute phase group as compared to those in healthy controls: 0.971 and 0.889, respectively, and miR-422a in the acute phase group as compared to healthy controls were 0.769. CONCLUSION: Plasma exosomal miR-422a and miR-125b-2-3p may serve as blood-based biomarkers for monitoring and diagnosing in IS patients, with plasma exosomal miR-422a showing the best diagnostic value. The use of these two plasma exosomal miRNAs in combination may be powerful for determining IS stage.

Effects of Mo(VI) on phototrophic hydrogen production by Rhodobacter sphaeroides.

Effects of Mo(6+) concentration on phototrophic hydrogen production of Rhodobacter sphaeroides were investigated using lactate as the sole carbon source. Results showed that an increase of Mo(6+) from nil to 1000 microg l(-1) led to increases in hydrogen yield, maximum production rate, conversion efficiency, biomass yield and lactate removal. At 100 microg-Mo l(-1), the maximum rate was 12.0 ml h(-1) with a conversion efficiency of 36.1%, the cell yields were 1.11 g-cell g(-1) -lactate and 2.4 g-cell g(-1)-TOC removed. Further increase of Mo(6+) improved hydrogen production only marginally. Degradation of lactate by R. sphaeroides produced not just hydrogen but also acetate, butyrate, i-valerate, i-caproate, hexanoate and some unidentified organic intermediates, but did not produce propionate and alcohols. Nitrogenase activity, as measured by the acetylene reduction method, had no clear correlation with either Mo(6+) concentration or hydrogen yield.

[Cantharidin regulates intracellular ATP in G1/S-phase renal tubule epithelial cells].

OBJECTIVE: To study the mechanism of cantharidin in protecting F-actin microfilaments from disruption by hypoxic damage by observing the effects of cantharidin on intracellular ATP metabolism in G(1)/S-phase renal tubule epithelial cells (RTECs). METHODS: G1-phase RTECs were divided into cantharidin-treated group, exposed to sodium cyanide (CN) and cantharidin, hypoxic-group with CN exposure and non-treated control group. ATP levels were measured in the 3 groups with high-performance liquid chromatography. RESULTS: The concentration of CN exposure for 1 h, ATP level in the RTECs with cantharidin treatment were significantly higher than that in both hypoxic and non-treated control groups (14.50+/-0.26 mmol/g protein, 4.25+/-0.11 mmol/g protein, 8.58+/-0.13 mmol/g protein, respectively, P<0.01). CONCLUSION: Cantharidin prevents the disruption of the actin cytoskeleton in hypoxic damage by preventing abnormal intracellular ATP metabolism.